Clinical Trials Browser

Phase 1/2 × Interventional × gossypol acetic acid × Clear all

NCT01003769 2020-06-16

Lenalidomide and AT-101 in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia

Phase 1/2 Terminated

5 enrolled 7 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT00561197 2013-01-04

An Open-label, Single-center, Phase 1/ 2 Study of Chemoradiotherapy and AT-101 in Patients With Locally Advanced Esophageal or Gastroesophageal Junction Cancer

Phase 1/2 Terminated

Gastrointestinal

Locally Advanced Esophageal or GE Junction Cancer

NCT00286793 2011-06-29

Safety and Efficacy Study of AT-101 in Combination With Docetaxel and Prednisone in Men With HRPC

Phase 1/2 Completed

Neoplasms, Prostatic Neoplasms

NCT00286806 2010-08-24

A Study of Single-Agent AT-101 in Men With Hormone Refractory Prostate Cancer

Phase 1/2 Completed

Hormone Refractory Prostate Cancer

NCT00397293 2010-08-24

Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer

Phase 1/2 Completed

Neoplasms, Small Cell Lung Carcinoma